BackAntisense Therapeutics Limited Overview
Antisense Therapeutics Limited

Antisense Therapeutics Limited PEG Ratio

Antisense Therapeutics Limited (ATHJF) has a PEG ratio of -4.18, below the sector sector average of -0.06.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-4.18

PEG Ratio

-4.18

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Antisense Therapeutics Limited (ATHJF) FAQ

The latest PEG ratio for ATHJF is -4.18. That is below the sector sector average of -0.06. Investors often review this figure alongside Antisense Therapeutics Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, ATHJF currently prints -4.18 for PEG ratio, while the sector average sits near -0.06. That is roughly 7036.7% below the sector mean. Large gaps often invite a closer look at Antisense Therapeutics Limited's growth, margins, and balance sheet.

A PEG ratio of -4.18 for Antisense Therapeutics Limited is not 'good' or 'bad' on its own. Compare it with the peer average (-0.06) and with ATHJF's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting ATHJF's PEG ratio (-4.18), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.